PD

Paul Da Silva Jardine

Venture Partner at Apple Tree Partners

Guilford, Connecticut

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Pharmaceutical Industry
Life Sciences
Biotechnology
Biomarkers
Clinical Trials
Cardiovascular Disease
Clinical Development
Chemistry
Drug Development
Clinical Research
Drug Discovery
Oncology

Education

Investments

Red Queen Therapeutics

Series A

Total Funding: $55M

Deep Apple Therapeutics

Series A

Total Funding: $52M

Aethon Therapeutics

Series A

Total Funding: $30M

Work Experience

Apple Tree Partners

2021

  • Venture Partner

    2021

Staten Biotechnology

2015

  • Chief Scientific Officer

    2015

    Staten Biotechnology is a Precision Medicine Cardiovascular and Dyslipidemic company for targets with robust human genetics support

Pfizer

1989 - 2015

  • Vice President Cardiovascular and Metabolic Research

    2009 - 2015

  • Vice President, Head of Cardiovascular and Metabolic and Endocrine Diseases Chemistry

    2004 - 2009

  • Senior Director, Head of Obesity and Osteoporosis Chemistry CVMED

    2001 - 2004

  • Research Scientist to Director Chemistry

    1989 - 2001